Factsheets & Guidelines

OHCHR Releases New UPR Submission Guidelines

The Office of the High Commissioner for Human Rights (OHCHR) has released new guidelines for stakeholder reports in the third cycle.

FAQ: The Abortion Pill Mifegymiso

On 29 July 2015, Health Canada approved the use of the medical abortion drug RU-486 (also known as Mifepristone).

The Politics of Mifegymiso in Canada: Key Dates and Milestones

July 2015: Health Canada approves the abortion pill Mifegymiso, the Canadian brand name for the combination of Mifepristone and Misoprostol. January 2017: Mifegymiso roll-out begins.

Need Immediate Help?

For information about sexual and reproductive health, including pregnancy options, and for referrals to clinics and hospitals that provide reproductive health services, including abortion, anywhere in Canada, please call the confidential 24-hour toll-free information and referral line.